Canada · Health Canada Drug Product Database

EFAMOL CALCIUM - CAP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 20326
DIN: 02163993
Form: Capsule
Company as listed by source: EFAMOL RESEARCH INC.
Source status: Cancelled Post Market (1999-10-25)
Source last updated: 2025-03-22

Source-listed ingredients

CIS-LINOLEIC ACID (EVENING PRIMROSE OIL) — 255 MG
GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL) — 30 MG
CALCIUM (CALCIUM CARBONATE) — 100 MG
D-ALPHA TOCOPHERYL ACETATE — 13.6 UNIT

These values do not establish equivalence or a dose recommendation.

Packages

60/90/120 Capsules

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →